"He would have known that he could have made people very sick and he literally was so greedy and just kept doing it,"she said
Plaintiffs argue that the manufacturers knew or should have known about these risks based on clinical data, adverse event reports, medical literature, and post-market safety information
Through PINK1/Parkin-induced and syntaxin 17-mediated pathways, MDVs selectively route oxidized cargo to lysosomes, providing a steady-state quality control route independent of canonical mitophagy (23,58)
Therefore, a safe switch from tirzepatide to semaglutide is never improvised
While this therapy is generally well-tolerated, you can reduce your risk of side effects by following the right steps and staying in close contact with your doctor